======= SGOL1 ======= == Gene Information == * **Official Symbol**: SGO1 * **Official Name**: shugoshin 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=151648|151648]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5FBB7|Q5FBB7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SGOL1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SGOL1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609168|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a member of the shugoshin family of proteins. This protein is thought to protect centromeric cohesin from cleavage during mitotic prophase by preventing phosphorylation of a cohesin subunit. Reduced expression of this gene leads to the premature loss of centromeric cohesion, mis-segregation of sister chromatids, and mitotic arrest. Evidence suggests that this protein also protects a small subset of cohesin found along the length of the chromosome arms during mitotic prophase. An isoform lacking exon 6 has been shown to play a role in the cohesion of centrioles (PMID: 16582621 and PMID:18331714). Mutations in this gene have been associated with Chronic Atrial and Intestinal Dysrhythmia (CAID) syndrome, characterized by the co-occurrence of Sick Sinus Syndrome (SSS) and Chronic Intestinal Pseudo-obstruction (CIPO) within the first four decades of life (PMID:25282101). Fibroblast cells from CAID patients exhibited both increased cell proliferation and higher rates of senescence. Pseudogenes of this gene have been found on chromosomes 1 and 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2015]. * **UniProt Summary**: N/A |Shugoshin C| |Shugoshin N| |mitotic sister chromatid cohesion, centromeric| |centromeric sister chromatid cohesion| |condensed chromosome, centromeric region| |centriole-centriole cohesion| |condensed nuclear chromosome, centromeric region| |mitotic sister chromatid cohesion| |attachment of spindle microtubules to kinetochore| |sister chromatid cohesion| |chromosome, centromeric region| |centrosome cycle| |kinetochore| |condensed chromosome kinetochore| |meiotic chromosome segregation| |microtubule organizing center organization| |kinase binding| |mitotic sister chromatid segregation| |spindle pole| |sister chromatid segregation| |mitotic nuclear division| |meiotic nuclear division| |meiotic cell cycle process| |nuclear chromosome segregation| |meiotic cell cycle| |chromosome segregation| |nuclear division| |organelle fission| |microtubule cytoskeleton organization| |centrosome| |cell division| |mitotic cell cycle process| |microtubule-based process| |mitotic cell cycle| |cell cycle process| |chromosome organization| |cytoskeleton organization| |cell cycle| |reproductive process| |reproduction| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|-2.4| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-2.36| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-2.02| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|-1.98| |[[:results:exp453|B02 10μM R08 exp453]]|-1.86| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|1.75| |[[:results:exp532|TIC10 10μM R08 exp532]]|1.85| |[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|2.24| |[[:results:exp93|DABN racemic mixture R03 exp93]]|2.27| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|2.35| |[[:results:exp33|Rotenone 2μM R00 exp33]]|3.05| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|4.52| ^Gene^Correlation^ |[[:human genes:h:hspd1|HSPD1]]|0.448| |[[:human genes:r:rpp21|RPP21]]|0.445| |[[:human genes:a:anapc15|ANAPC15]]|0.424| |[[:human genes:s:srpk1|SRPK1]]|0.422| |[[:human genes:a:anapc13|ANAPC13]]|0.41| |[[:human genes:a:aspm|ASPM]]|0.409| |[[:human genes:d:ddx55|DDX55]]|0.407| |[[:human genes:a:alg1|ALG1]]|0.404| |[[:human genes:f:fnta|FNTA]]|0.404| |[[:human genes:u:utp23|UTP23]]|0.403| |[[:human genes:a:adsl|ADSL]]|0.401| |[[:human genes:t:thg1l|THG1L]]|0.401| Global Fraction of Cell Lines Where Essential: 354/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|16/28| |blood|12/28| |bone|12/26| |breast|15/33| |central nervous system|22/56| |cervix|3/4| |colorectal|7/17| |esophagus|7/13| |fibroblast|0/1| |gastric|9/16| |kidney|13/21| |liver|12/20| |lung|40/75| |lymphocyte|9/16| |ovary|15/26| |pancreas|16/24| |peripheral nervous system|9/16| |plasma cell|3/15| |prostate|0/1| |skin|11/24| |soft tissue|5/9| |thyroid|1/2| |upper aerodigestive|14/22| |urinary tract|12/29| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16948 * **Expression level (log2 read counts)**: 5.03 {{:chemogenomics:nalm6 dist.png?nolink |}}